Transcriptional regulators ensuring specific gene expression and decision-making at high TGF{beta} doses
Laura Hartmann,Panajot Kristofori,Congxin Li,Kolja Becker,Lorenz Hexemer,Stefan Bohn,Sonja Lenhardt,Sylvia Weiss,Björn Voss,Alexander Loewer,Stefan Legewie
DOI: https://doi.org/10.26508/lsa.202402859
IF: 5.781
2024-11-21
Life Science Alliance
Abstract:TGFβ-signaling regulates cancer progression by controlling cell division, migration, and death. These outcomes are mediated by gene expression changes, but the mechanisms of decision-making toward specific fates remain unclear. Here, we combine SMAD transcription factor imaging, genome-wide RNA sequencing, and morphological assays to quantitatively link signaling, gene expression, and fate decisions in mammary epithelial cells. Fitting genome-wide kinetic models to our time-resolved data, we find that most of the TGFβ target genes can be explained as direct targets of SMAD transcription factors, whereas the remainder show signs of complex regulation, involving delayed regulation and strong amplification at high TGFβ doses. Knockdown experiments followed by global RNA sequencing revealed transcription factors interacting with SMADs in feedforward loops to control delayed and dose-discriminating target genes, thereby reinforcing the specific epithelial-to-mesenchymal transition at high TGFβ doses. We identified early repressors, preventing premature activation, and a late activator, boosting gene expression responses for a sufficiently strong TGFβ stimulus. Taken together, we present a global view of TGFβ-dependent gene regulation and describe specificity mechanisms reinforcing cellular decision-making.
biology